Clinical Trials Browser

Observational × gemcitabine-oxaliplatin regimen × Gastrointestinal × Clear all

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT06505486 2024-07-17

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Gastrointestinal

Cholangiocarcinoma